Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Multiple sclerosis.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Shorter washout reduces MS relapse switching off natalizumab
Synthesis and biological evaluation of new 1,2-dihydro-4-hydroxy-2-oxo-3-quinolinecarboxamides for treatment of autoimmune disorders: structure-activity relationship.
Axonal conduction and injury in multiple sclerosis: the role of sodium channels.
BRIEF-AB Science says DSMB recommends continuation of phase 3 masitinib study
Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis.
Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
Changes to anti-JCV antibody levels in a Swedish national MS cohort.
Modeling probability of additional cases of natalizumab-associated JCV sero-negative progressive multifocal leukoencephalopathy.
White matter astrocytes in health and disease.
Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation.
The Brief Repeatable Battery: psychometrics and normative values with age, education and gender corrections in a Serbian population.
A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.
Prevention and treatment of MS: studying the effects of vitamin D.
Rapid depletion of B lymphocytes by ultra-low-dose rituximab delivered intrathecally.
Fingolimod modulates microglial activation to augment markers of remyelination.
A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis.
Biogen Idec announces positive top-line results from Phase 3 study of peginterferon beta-1a in multiple sclerosis
Centocor briefing document for Ustekinumab, submitted to FDA
Sex-related factors in multiple sclerosis susceptibility and progression.
The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group.
Demyelination affects temporal aspects of perception: An optic neuritis study.

Pages